Mitochondrial DNA (mtDNA) is a 16.6 kb genome that encodes for 13 of the 100+ subunits of the electron transfer chain (ETC), whilst the other subunits are encoded by chromosomal DNA. The ETC is responsible for the generation of the majority of cellular ATP through the process of oxidative phosphorylation (OXPHOS). mtDNA is normally inherited from the population present in the mature oocyte just prior to fertilisation. However, following somatic cell nuclear transfer (SCNT), mtDNA can be transmitted from both the donor cell and the recipient oocyte. This heteroplasmic transmission of mtDNA is a random event and does not appear to be related to the amount of mtDNA contributed by the donor cell. The distribution of mtDNA is randomly segregated between blastomeres and differentiating tissues, and therefore the mtDNA complement transmitted to offspring tissue cannot be predicted. mtDNA divergence between the cytoplast and the donor cell in intra- and inter-specific crosses favours a slightly more diverse mtDNA haplotype. However, this is limited as interspecies SCNT (iSCNT) genetic divergence contributes to developmental failure. SCNT embryos demonstrate a plethora of aberrantly reprogrammed characteristics including the uncoordinated regulation of the mtDNA replication factors. This results in increased mtDNA copy number during preimplantation development and propagates the replication of donor cell mtDNA. These failures are likely to be a consequence of incompatible nuclear- and mtDNA -encoded proteins interacting within the ETC thus reducing ATP production. The outcomes would be similar to the severely debilitating or even fatal mtDNA diseases associated with genetic rearrangements to mtDNA or mtDNA depletion type syndromes and have serious implications for any form of karyoplast transfer approach. The only method to overcome the problems of heteroplasmy in SCNT embryos is to completely deplete the donor cell of its mtDNA prior to SCNT.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1387/ijdb.103202rk | DOI Listing |
J Nanobiotechnology
January 2025
Biotechnology Center (BIOTEC) and Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Tatzberg 47-49, 01307, Dresden, Germany.
Extracellular membrane vesicles (EVs) offer promising values in various medical fields, e.g., as biomarkers in liquid biopsies or as native (or bioengineered) biological nanocarriers in tissue engineering, regenerative medicine and cancer therapy.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, C11, 75185, Uppsala, Sweden.
The existence of transmissible amyloid fibril strains has long intrigued the scientific community. The strain theory originates from prion disorders, but here, we provide evidence of strains in systemic amyloidosis. Human AA amyloidosis manifests as two distinct clinical phenotypes called common AA and vascular AA.
View Article and Find Full Text PDFCommun Biol
January 2025
Department of Cellular Architecture Studies, Division of Shionogi Global Infectious Diseases Division, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
The rapid intraerythrocytic replication of Plasmodium falciparum, a deadly species of malaria parasite, requires a quick but constant supply of phospholipids to support marked cell membrane expansion. In the malarial parasite, many enzymes functioning in phospholipid synthesis pathway have not been identified or characterized. Here, we identify P.
View Article and Find Full Text PDFSci Rep
January 2025
Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, China.
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer, notoriously refractory to conventional chemotherapy. Historically, sulfane sulfur-based compounds have been explored for the treatment of HCC, but their efficacy has been underwhelming. We recently reported a novel sulfane sulfur donor, PSCP, which exhibited improved chemical stability and structural malleability.
View Article and Find Full Text PDFNat Commun
January 2025
Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
Blood transfusion plays a vital role in modern medicine, but frequent shortages occur. Ex vivo manufacturing of red blood cells (RBCs) from universal donor cells offers a potential solution, yet the high cost of recombinant cytokines remains a barrier. Erythropoietin (EPO) signaling is crucial for RBC development, and EPO is among the most expensive media components.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!